Cat: PA2000-9521

Recombinant Human MTERFD3 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    MTERFD3

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    Hypothetical protein DKFZp667I1824 ; mitochondrial; Mitochondrial transcription termination factor 2; Mitochondrial transcription termination factor-like protein; MTER3_HUMAN; MTERF domain containing 3; mTERF domain-containing protein 3; mTERF domain-containing protein 3; mitochondrial; mTERF2; Mterfd3; mTERFL; Transcription termination factor 2 mitochondrial; Transcription termination factor like protein

  • Species

    Human

  • Source

    E. coli

  • Tag

    His tag N-Terminus

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q49AM1

  • Expression Region

    36-385 aa

  • AA Sequence

    TTDKQ SSKENTRTVE KLYKCSVDIR KIRRLKGWVL LEDETYVEEI ANILQELGAD ETAVASILER CPEAIVCSPT AVNTQRKLWQ LVCKNEEELI KLIEQFPESF FTIKDQENQK LNVQFFQELG LKNVVISRLL TAAPNVFHNP VEKNKQMVRI LQESYLDVGG SEANMKVWLL KLLSQNPFIL LNSPTAIKET LEFLQEQGFT SFEILQLLSK LKGFLFQLCP RSIQNSISFS KNAFKCTDHD LKQLVLKCPA LLYYSVPVLE ERMQGLLREG ISIAQIRETP MVLELTPQIV QYRIRKLNSS GYRIKDGHLA NLNGSKKEFE ANFGKIQAKK VRPLFNPVAP LNVEE

  • Molecular Weight

    44.4 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

MTERFD3 (MTERF domain-containing protein 3) has garnered significant interest in recent years due to its role in cellular processes and potential implications in health and disease. This protein is part of a family that includes mitochondrial transcription termination factor (MTERF) proteins, which are known to participate in the regulation of mitochondrial gene expression and maintenance of mitochondrial DNA. Research has highlighted that MTERFD3 is involved in various cellular functions, including apoptosis, energy metabolism, and stress responses. Dysregulation of MTERFD3 has been associated with several pathological conditions, including cancer and neurodegenerative diseases, which emphasizes its potential as a biomarker or therapeutic target. Understanding the molecular mechanisms underlying the function of MTERFD3 is essential, as it may reveal novel insights into mitochondrial biology and its influence on cellular health. Furthermore, the expression and activity of MTERFD3 can be modulated by various factors, making it a candidate for exploring the responses of cells to environmental stressors. Consequently, the study of recombinant MTERFD3 protein can enhance our understanding of its structure-function relationships and interactions with other biomolecules, potentially leading to advancements in therapeutic strategies for diseases linked to mitochondrial dysfunction. As research progresses, it is expected that more insights will emerge regarding the precise roles of MTERFD3 in cellular physiology and pathology, paving the way for innovative approaches in biomedical research and therapy.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US